Background: The binding of anti-acetylcholine receptor antibodies (AChRAb) to the main immunogenic region (MIR) of AChR α-subunit in the neuromuscular junction is the major pathogenesis of myasthenia gravis (MG). Methods: A synthetic peptide of 10 amino acids corresponding to the MIR of human AChR was coupled with cellulose beads to make an antigen-specific immunoadsorbent (hMIR10-CB). Results: The hMIR10-CB could remove AChRAb in MG sera by 40.3±2.3%, compared to a tryptophan nonspecific adsorbent Trp-CB by only 22.4±1.5% as determined in ELISA, and also showed good blood compatibility for blood cells, plasma ions and plasma proteins as checked in whole blood perfusion in rabbits. Conclusions: The antigen-specific immunoadsorbent hMIR10-CB can serve as a potential candidate in the immunoadsorption treatment of MG. © Informa UK Ltd.
CITATION STYLE
Sun, C., Meng, F., Li, Y., Jin, Q., Li, H., & Li, F. (2010). Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis. Artificial Cells, Blood Substitutes, and Biotechnology, 38(2), 99–102. https://doi.org/10.3109/10731191003634778
Mendeley helps you to discover research relevant for your work.